BioAtla (BCAB) Shares Outstanding (2020 - 2026)

BioAtla's Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 42.09% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $1.7 million, a 42.09% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 9.23% from the prior year.
• Shares Outstanding (Entity) improved to $1.7 million in Q1 2026 per BCAB's latest filing, from $1.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $1.7 million in Q1 2026 and bottomed at $717826.0 in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $962126.0 (2024), against an average of $1.0 million.
• Across the five-year window, Shares Outstanding (Entity) rose 0.91% in 2024 and soared 42.09% in 2026, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $926723.0 in 2022, then climbed by 3.76% to $961552.0 in 2023, then gained by 20.84% to $1.2 million in 2024, then gained by 9.23% to $1.3 million in 2025, then jumped by 30.75% to $1.7 million in 2026.
• Per Business Quant, the three latest BCAB Shares Outstanding (Entity) figures stand at $1.7 million (Q1 2026), $1.3 million (Q4 2025), and $1.2 million (Q3 2025).